𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of flow cytometric predictive biomarker assay for response to PARP inhibitor (PARPi) therapy in high-grade serous ovarian cancer (HGSOC)

✍ Scribed by Lee, J.M.; Gordon, N.; Lee, M.J.; Trepel, J.; Yu, M.; Kohn, E.C.


Book ID
127031834
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
53 KB
Volume
133
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.